Professor/ Vice chair
University of Virginia
University of Virginia School of Medicine
Charlottesville, VA, United States
Prof. Dr. Ziv J. Haskal is a tenured professor at the University of Virginia School of Medicine. His research has spanned the breadth of IR, beginning with defining early research. His research has included preclinical validation and in-human interventional trans-arterial gene vector; the first demonstration of IR radiation eye injury risks at occupational levels; trials in accelerated pharmacomechanical deep vein interventions; advances in hemodialysis access care, including randomized trials of dialysis stent grafts that defined the first proven superior intervention for AV graft stenosis, benefiting thousands worldwide; liver transplant interventions; all aspects of embolization; and interventional oncology. He has published over 400 manuscripts, abstracts, chapters, books, letters, and editorials in journals such as the New England Journal of Medicine, Human Gene Therapy, Circulation, Hepatology, Radiology, CVIR, AJR, and JVIR. His papers have been cited thousands of times – the AHA/ACC PAD Guideline he co-chaired and co-wrote, alone, has been cited over 5300 times,his papers overall, >17,000 times. His H-index is >60. Prof. Haskal has led or participated in over 50 human and animal research studies.
His pivotal NEJM trial defined the use of all stent grafts in AV Access.
Prof. Haskal has given more than 700 invited lectures worldwide and been awarded numerous honorary fellowships, gold medals, named lectures, and received multiple of the highest national and international societal awards for innovation, leadership, service, career and research excellence, and served in many societal leadership and committee positions. He served two terms as the JVIR editor-in-chief (10 years) during which he nearly tripled its submissions, raised the impact factor, and 1000s of trainees in writing seminars.
Disclosure information not submitted.
Friday, October 4, 2024
9:35 AM – 10:00 AM US Eastern
Friday, October 4, 2024
2:15 PM – 3:00 PM US Eastern
Session VII: New Methods, Early Results, Clinical Trials, and Innovation
Saturday, October 5, 2024
8:00 AM – 10:00 AM US Eastern